Skip to main content

Table 2 Post-conception folic acid supplementation and risk of congenital malformations

From: Initiation and duration of folic acid supplementation in preventing congenital malformations

Variants of folic acid supplementation

Risk of congenital malformations

No. of malformations

No. of infants

Prevalence,% (95% CI)

Adjusted odds ratio (95% CI)a

P value

Supplementation

 No

21

887

2.37 (1.37–3.37)

1.00

 

 Yes

128

8695

1.47 (1.22–1.73)

0.64 (0.40–1.03)

0.063

Initiation

 No supplement

21

887

2.37 (1.37–3.37)

1.00

 

 The first month

57

4430

1.29 (0.95–1.62)

0.55 (0.33–0.91)

0.02

 The second month

51

3343

1.53 (1.11–1.94)

0.64 (0.38–1.07)

0.086

 The third month

20

922

2.17 (1.23–3.11)

0.91 (0.49–1.70)

0.77

Duration

 No supplement

21

887

2.37 (1.37–3.37)

1.00

 

 1 month

33

1993

1.66 (1.10–2.22)

0.68 (0.39–1.19)

0.17

 1.01 months ~ 

63

4572

1.38 (1.04–1.72)

0.59 (0.36–0.98)

0.041

 2.01 months ~ 

32

2130

1.50 (0.99–2.02)

0.66 (0.38–1.17)

0.15

  1. aAdjusted for region, maternal age, ethnicity, parity, conception mode, education level, family income, history of adverse pregnancy outcomes, medicine exposure, and early pregnancy conditions